14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Oct 30, 2018 $0.0600 $0.0690 $0.0600 $0.0621 45 649
Oct 29, 2018 $0.0600 $0.0685 $0.0600 $0.0621 21 909
Oct 26, 2018 $0.0651 $0.0700 $0.0615 $0.0700 112 323
Oct 25, 2018 $0.0699 $0.0699 $0.0652 $0.0652 54 332
Oct 24, 2018 $0.0728 $0.0728 $0.0680 $0.0690 150 570
Oct 23, 2018 $0.0728 $0.0728 $0.0702 $0.0702 36 379
Oct 22, 2018 $0.0711 $0.0741 $0.0702 $0.0722 99 313
Oct 19, 2018 $0.0750 $0.0778 $0.0711 $0.0711 51 680
Oct 18, 2018 $0.0705 $0.0800 $0.0705 $0.0720 158 660
Oct 17, 2018 $0.0706 $0.0759 $0.0705 $0.0750 127 147
Oct 16, 2018 $0.0726 $0.0759 $0.0705 $0.0728 92 144
Oct 15, 2018 $0.0800 $0.0810 $0.0720 $0.0740 93 144
Oct 12, 2018 $0.0722 $0.0840 $0.0705 $0.0750 150 557
Oct 11, 2018 $0.0705 $0.0780 $0.0705 $0.0705 38 774
Oct 10, 2018 $0.0705 $0.0845 $0.0705 $0.0780 34 828
Oct 09, 2018 $0.0855 $0.0855 $0.0722 $0.0735 73 551
Oct 08, 2018 $0.0722 $0.0845 $0.0722 $0.0800 101 244
Oct 05, 2018 $0.0720 $0.0840 $0.0720 $0.0741 34 489
Oct 04, 2018 $0.0725 $0.0840 $0.0724 $0.0724 43 353
Oct 03, 2018 $0.0839 $0.0848 $0.0766 $0.0779 99 824
Oct 02, 2018 $0.0701 $0.0848 $0.0700 $0.0848 205 775
Oct 01, 2018 $0.0751 $0.0759 $0.0701 $0.0750 93 054
Sep 28, 2018 $0.0741 $0.0820 $0.0741 $0.0751 53 654
Sep 27, 2018 $0.0835 $0.0869 $0.0752 $0.0780 49 364
Sep 26, 2018 $0.0708 $0.0862 $0.0705 $0.0835 39 015
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT